CorMedix CRMD Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Accrued Compensation
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Accrued Compensation at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept crmd:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsAccruedCompensation.
The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about CorMedix's deferred tax assets tax deferred expense compensation and benefits accrued compensation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CorMedix's deferred tax assets tax deferred expense compensation and benefits accrued compensation?
- CorMedix (CRMD) reported deferred tax assets tax deferred expense compensation and benefits accrued compensation of $3.5M in Q4 2025.
- What is the long-term trend for CorMedix's deferred tax assets tax deferred expense compensation and benefits accrued compensation?
- Over 3 years (2022 to 2025), CorMedix's deferred tax assets tax deferred expense compensation and benefits accrued compensation has grown at a 172.9% compound annual growth rate (CAGR), from $172K to $3.5M.
- What does deferred tax assets tax deferred expense compensation and benefits accrued compensation mean?
- This represents the tax benefit associated with accrued compensation and benefits that are recognized for financial reporting but are not yet deductible for tax purposes. It reflects the future tax savings the company will realize when these expenses are paid and become tax-deductible. This metric provides insight into the timing differences between accounting and tax recognition of personnel costs.